Skip to main content
Equibles

PMA · PMA Graphene Technology Group Inc. · Documents

Track PMA — free

Use PMA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PMA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.21 -0.04 (-3.20%) At close · Nov 12
Rebalance outlook locked
Market Cap
$197.20M
Shares
162.97M
Volume · Nov 12 8125 Avg daily vol (3M) 55.69K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2026 Revenue $14.63M down 56.8% 20-F filed Aug 17, 2026
2026
Nov 5
Current report 6-K
Acquisition closes with US$510,000,000 securities-only consideration

PMA Graphene Technology Group Inc. completed its acquisition of Meals Through Seasons Limited on September 2, 2026, for US$510,000,000 payable entirely in securities, with no cash payable.

3 source passages
On September 2, 2026, PMA Graphene Technology Group Inc. completed an acquisition, as discussed below. On September 2, 2026, the Company completed the acquisition of the entire issued share capital of Meals Through Seasons Limited (“MTS”), pursuant to a stock purchase agreement (the “SPA”) with Hongs Smart Limited and Yapjianhuei Smart Limited (collectively the “Sellers”). The aggregate consideration of US$510,000,000 is payable in full in securities of the Company, and no cash is payable by the Company. Open the document at this passage
Aug 17
Annual report 20-F FY2026, ended Mar 31
Annual report for FY2026 AI summary on its way
Revenue $14.63M ▼ 56.8% Net loss $5.76M Diluted EPS -$0.44
2025
Aug 15
Annual report 20-F FY2025, ended Mar 31
Annual report for FY2025
Revenue $33.85M ▲ 22.8% Net loss $5.73M Diluted EPS -$0.48
2024
Showing 1–50 of 61 documents
Key facts CIK 1956166 CUSIP G61440106 13F (30d) 3 filings 3 filers Visit website Investor relations